Physician profile
Mark A Kallgren
NPI 1700841541
$24,478.78
in general payments reported to CMS, 2019-2025
32 companies · $982 in 2025
The $982 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $5,934 · 2021: $3,803 · 2022: $1,225 · 2023: $1,174 · 2024: $985 · 2025: $982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,711 · Travel and Lodging: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,711.13 |
| Travel and Lodging | $428.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $19,489.32 | 2019-2021 | |
| Abbott Laboratories | $1,013.07 | 2021-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $776.99 | 2021-2025 | General - Vascular Intervention, Click |
| Mml US, INC. | $453.97 | 2024 | Reactiv8 |
| Amgen INC. | $381.45 | 2021-2023 | |
| Medtronic, INC. | $341.70 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Nevro Corp. | $340.47 | 2021-2024 | Senza |
| Avanos Medical | $180.83 | 2019-2024 | Trivisc Sodium Hyaluronate |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Relievant Medsystems, INC. | $172.83 | 2023 | Intracept |
| Abbvie INC. | $169.70 | 2022-2025 | |
| Curonix LLC | $165.31 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $159.94 | 2023-2024 | Nalu Neurostimulation System |
| Scilex Pharmaceuticals INC. | $107.42 | 2021-2023 | Ztlido |
| Collegium Pharmaceutical, INC. | $55.64 | 2023 | Belbuca |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $51.57 | 2021-2022 | |
| Globus Medical, INC. | $47.57 | 2025 | Omnia |
| Protega Pharmaceutials INC | $44.71 | 2024 | Roxybond |
| Pacira Pharmaceuticals Incorporated | $39.78 | 2022 | |
| Redhill Biopharma INC. | $34.62 | 2022 | |
| Saluda Medical Americas, INC. | $34.20 | 2023 | Evoke Scs |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.37 | 2022 | |
| Arbor Pharmaceuticals, INC. | $29.21 | 2022 | |
| Almatica Pharma LLC | $28.06 | 2022 | |
| Averitas Pharma INC. | $25.50 | 2023 | Qutenza |
| Bioventus LLC | $22.38 | 2024 | Durolane |
| Vertex Pharmaceuticals Incorporated | $19.46 | 2025 | |
| Vertos Medical, INC. | $18.65 | 2023 | Mild Device Kit |
| Alfasigma USA, INC. | $16.60 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.49 | 2023 | |
| Hikma Pharmaceuticals USA | $14.74 | 2022 | |
| Spinal Simplicity, LLC | $13.80 | 2025 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kallgren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.